-
1 Comment
Owens & Minor, Inc is currently in a long term uptrend where the price is trading 31.9% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.3.
Owens & Minor, Inc's total revenue rose by 26.5% to $2B since the same quarter in the previous year.
Its net income has increased by 230.0% to $51M since the same quarter in the previous year.
Finally, its free cash flow grew by 196.1% to $38M since the same quarter in the previous year.
Based on the above factors, Owens & Minor, Inc gets an overall score of 5/5.
ISIN | US6907321029 |
---|---|
Industry | Medical Distribution |
Sector | Healthcare |
CurrencyCode | USD |
Exchange | NYSE |
Beta | 0.6 |
---|---|
Market Cap | 1B |
PE Ratio | 50.0 |
Target Price | 20.67 |
Dividend Yield | 0.1% |
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment supplies a range of other home medical equipment, patient care products, including ostomy, wound care, urology, incontinence and other products and services. It serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. The company was founded in 1882 and is headquartered in Richmond, Virginia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for OMI using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024